INSMED Trademark

Trademark Overview

On Thursday, January 27, 2022, a trademark application was filed for INSMED with the United States Patent and Trademark Office. The USPTO has given the INSMED trademark a serial number of 97241454. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, May 10, 2024. This trademark is owned by Insmed Incorporated. The INSMED trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of rare pulmonary and rare neuromuscular diseases; pharmaceutical preparations for the treatment of orphan pulmonary and orphan neuromuscular diseases; pharmaceutical preparations for the treatment of genetic disorders and diseases
insmed

General Information

Serial Number97241454
Word MarkINSMED
Filing DateThursday, January 27, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, May 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of rare pulmonary and rare neuromuscular diseases; pharmaceutical preparations for the treatment of orphan pulmonary and orphan neuromuscular diseases; pharmaceutical preparations for the treatment of genetic disorders and diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInsmed Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807
Party NameInsmed Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Monday, January 31, 2022NEW APPLICATION ENTERED
Tuesday, February 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 26, 2022ASSIGNED TO EXAMINER
Tuesday, July 26, 2022NON-FINAL ACTION WRITTEN
Tuesday, July 26, 2022NON-FINAL ACTION E-MAILED
Tuesday, July 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 26, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 26, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, October 26, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 26, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, October 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 14, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 20, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 20, 2023SOU EXTENSION 1 FILED
Thursday, July 20, 2023SOU EXTENSION 1 GRANTED
Saturday, July 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024SOU EXTENSION 2 FILED
Wednesday, January 17, 2024SOU EXTENSION 2 GRANTED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 10, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 10, 2024SOU EXTENSION 3 FILED
Friday, May 10, 2024SOU EXTENSION 3 GRANTED
Saturday, May 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

insmed pharmaceutical diseases treatment preparations orphan pulmonary neuromuscular rare disorders genetic